Randomized, Double-Blind, Multicenter Trial of Hydrogen Water for Parkinson's Disease

被引：25

作者：

Yoritaka, Asako ^{[1
,2
]}

Ohtsuka, Chigumi ^{[3
]}

Maeda, Tetsuya ^{[3
,4
]}

Hirayama, Masaaki ^{[5
]}

Abe, Takashi ^{[6
]}

Watanabe, Hirohisa ^{[7
]}

Saiki, Hidemoto ^{[8
]}

Oyama, Genko ^{[2
]}

Fukae, Jiro ^{[9
]}

Shimo, Yasushi ^{[2
]}

Hatano, Taku ^{[2
]}

Kawajiri, Sumihiro ^{[10
]}

Okuma, Yasuyuki ^{[10
]}

Machida, Yutaka ^{[11
]}

Miwa, Hideto ^{[11
]}

Suzuki, Chikako ^{[12
]}

Kazama, Asuka ^{[13
]}

Tomiyama, Masahiko ^{[14
]}

Kihara, Takeshi ^{[15
]}

Hirasawa, Motoyuki ^{[16
]}

Shimura, Hideki ^{[17
]}

Oda, Eisei

Ito, Mikako ^{[18
]}

Ohno, Kinji ^{[19
]}

Hattori, Nobutaka ^{[2
]}

机构：

[1] Juntendo Univ, Koshigaya Hosp, Dept Neurol, Fukuroyama 560, Koshigaya, Saitama 3430032, Japan

[2] Juntendo Univ, Sch Med, Dept Neurol, Tokyo, Japan

[3] Iwate Med Univ, Dept Internal Med, Sch Med, Div Neurol & Gerontol, Morioka, Iwate, Japan

[4] Res Inst Brain & Blood Vessels, Dept Neurol, Akita, Japan

[5] Nagoya Univ, Grad Sch Med, Dept Pathophysiol Lab Sci, Nagoya, Aichi, Japan

[6] Abe Neurol Clin, Dept Neurol, Morioka, Iwate, Japan

[7] Nagoya Univ, Brain & Mind Res Ctr, Nagoya, Aichi, Japan

[8] Kitano Hosp, Tazuke Kofukai Med Res Inst, Dept Neurol, Osaka, Japan

[9] Fukuoka Univ, Dept Neurol, Fukuoka, Japan

[10] Juntendo Univ, Dept Neurol, Shizuoka Hosp, Shizuoka, Japan

[11] Juntendo Univ, Dept Neurol, Nerima Hosp, Tokyo, Japan

[12] Karolinska Univ Hosp, Karolinska Inst, Dept Mol Med & Surg, Dept Diagnost Radiol, Stockholm, Sweden

[13] Nozomi Hosp, Saitama, Japan

[14] Aomori Prefectural Cent Hosp, Dept Neurol, Aomori, Japan

[15] Rakuwakai Otowa Rehabil Hosp, Dept Neurol, Kyoto, Japan

[16] Tokyo Rinkai Hosp, Dept Neurol, Tokyo, Japan

[17] Juntendo Univ, Urayasu Hosp, Dept Neurol, Chiba, Japan

[18] AC Med Inc, Tokyo, Japan

[19] Nagoya Univ, Grad Sch Med, Ctr Neurol Dis & Canc, Div Neurogenet, Nagoya, Aichi, Japan

来源：

MOVEMENT DISORDERS | 2018年 / 33卷 / 09期

基金：

日本学术振兴会;

关键词：

D O I：

10.1002/mds.27472

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：1505 / 1507

页数：3

共 50 条

[21] Methotrexate in chronic active Crohn's disease: A double-blind, randomized, Israeli multicenter trial
Oren, R
Moshkowitz, M
Odes, S
Becker, S
Keter, D
Pomeranz, I
Shirin, C
Reisfeld, I
Broide, E
Lavy, A
Fich, A
Eliakim, R
Patz, J
Villa, Y
Arber, N
Gilat, T
AMERICAN JOURNAL OF GASTROENTEROLOGY, 1997, 92 (12): : 2203 - 2209
[22] Effects of ETyrosine on Parkinson's Disease: A Randomized, Double-Blind, Placebo-Controlled Trial
DiFrancisco-Donoghue, Joanne
Rabin, Ely
Lamberg, Eric M.
Werner, William G.
MOVEMENT DISORDERS CLINICAL PRACTICE, 2014, 1 (04): : 348 - 353
[23] Pramipexole Ameliorates Depression in Parkinson's Disease: A Randomized Double-Blind Versus Placebo Trial
Barone, Paolo
Poewe, Werner
Massey, Dan
Debieuvre, Catherine Debove
NEUROLOGY, 2009, 72 (11) : A413 - A413
[24] Double-blind, randomized, controlled trial of rasagiline as monotherapy in early Parkinson's disease patients
Stern, MB
Marek, KL
Friedman, J
Hauser, RA
LeWitt, PA
Tarsy, D
Olanow, CW
MOVEMENT DISORDERS, 2004, 19 (08) : 916 - 923
[25] A double-blind randomized controlled trial of cognitive training for freezing of gait in Parkinson's disease
Walton, C. C.
Mowszowski, L.
Shine, J. M.
Gilat, M.
Hall, J. M.
O'Callaghan, C.
Muller, A. J.
Georiades, M.
Szeto, J. Y. Y.
Martens, K. A. Ehgoetz
Naismith, S. L.
Lewis, S. J. G.
MOVEMENT DISORDERS, 2016, 31 : S694 - S695
[26] A Randomized, Double-Blind, Placebo-Controlled Trial of Levetiracetam for Dyskinesia in Parkinson's Disease
Wong, Kitty K.
Alty, Jane E.
Goy, Amanda G.
Raghav, Sanjay
Reutens, David C.
Kempster, Peter A.
MOVEMENT DISORDERS, 2011, 26 (08) : 1552 - 1555
[27] A randomized double-blind placebo-controlled trial of probiotics for constipation in Parkinson's disease
Chong, K. K.
Lim, S. Y.
Manap, M. A. A. A.
Lim, J. L.
Low, S. C.
Mahadeva, S. K.
Tan, A. H.
MOVEMENT DISORDERS, 2018, 33 : S194 - S194
[28] A Double-Blind, Randomized, Controlled Trial of Lovastatin in Early-Stage Parkinson's Disease
Lin, Chin-Hsien
Chang, Chin-Hao
Tai, Chun-Hwei
Cheng, Mei-Fang
Chen, Yi-Chieh
Chao, Ying-Ting
Huang, Tse-Le
Yen, Ruoh-Fang
Wu, Ruey-Meei
MOVEMENT DISORDERS, 2021, 36 (05) : 1229 - 1237
[29] A randomized double-blind multi-center trial of hydrogen water for Parkinson's disease: protocol and baseline characteristics (vol 16, 66, 2016)
Yoritaka, Asako
Abe, Takashi
Ohtsuka, Chigumi
Maeda, Tetsuya
Hirayama, Masaaki
Watanabe, Hirohisa
Saiki, Hidemoto
Oyama, Genko
Fukae, Jiro
Shimo, Yasushi
Hatano, Taku
Kawajiri, Sumihiro
Okuma, Yasuyuki
Machida, Yutaka
Miwa, Hideto
Suzuki, Chikako
Kazama, Asuka
Tomiyama, Masahiko
Kihara, Takeshi
Hirasawa, Motoyuki
Shimura, Hideki
Hattori, Nobutaka
BMC NEUROLOGY, 2017, 17 : 1 - 2
[30] Perampanel in Parkinson Disease Fluctuations: A Double-Blind Randomized Trial With Placebo and Entacapone
Rascol, Olivier
Barone, Paolo
Behari, Madhuri
Emre, Murat
Giladi, Nir
Olanow, C. Warren
Ruzicka, Evzen
Bibbiani, Francesco
Squillacote, David
Patten, Anna
Tolosa, Eduardo
CLINICAL NEUROPHARMACOLOGY, 2012, 35 (01) : 15 - 20

← 1 2 3 4 5 →